{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:04:41Z","timestamp":1792919081796,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":419,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1093\/annonc\/mdy250","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T10:05:31Z","timestamp":1531476331000},"page":"1926-1931","source":"Crossref","is-referenced-by-count":62,"title":["Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18"],"prefix":"10.1016","volume":"29","author":[{"given":"C.-A.","family":"Voltin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Goergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Baues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kreissl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Oertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Klaeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Drzezga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Borchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dietlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1093\/annonc\/mdy250_bb0010","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1093\/annonc\/mdy250_bb0015","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 Trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1093\/annonc\/mdy250_bb0020","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1200\/JCO.2012.43.4803","article-title":"Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)","volume":"31","author":"Gordon","year":"2013","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1093\/annonc\/mdy250_bb0025","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin\u2019s lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"issue":"10114","key":"10.1093\/annonc\/mdy250_bb0030","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","article-title":"PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group","volume":"390","author":"Borchmann","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"10.1093\/annonc\/mdy250_bb0035","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"issue":"11","key":"10.1093\/annonc\/mdy250_bb0040","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1093\/annonc\/mdy250_bb0045","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2141.2003.04329.x","article-title":"Bone marrow biopsy morbidity and mortality","volume":"121","author":"Bain","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1093\/annonc\/mdy250_bb0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.bjc.6601561","article-title":"Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma","volume":"90","author":"Naumann","year":"2004","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1093\/annonc\/mdy250_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdj024","article-title":"Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET\/CT era?","volume":"17","author":"Raanani","year":"2006","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdy250_bb0060","first-page":"482","article-title":"Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma","volume":"91","author":"Hutchings","year":"2006","journal-title":"Haematologica"},{"issue":"12","key":"10.1093\/annonc\/mdy250_bb0065","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00277-007-0356-9","article-title":"Positron emission tomography in the staging of patients with Hodgkin's lymphoma: a prospective multicentric study by the Intergruppo Italiano Linfomi","volume":"86","author":"Rigacci","year":"2007","journal-title":"Ann Hematol"},{"issue":"27","key":"10.1093\/annonc\/mdy250_bb0070","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1093\/annonc\/mdy250_bb0075","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2015-11-679407","article-title":"PET-CT for staging and early response: results from the response-adapted therapy in advanced Hodgkin lymphoma study","volume":"127","author":"Barrington","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1093\/annonc\/mdy250_bb0080","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00259-009-1377-5","article-title":"18F-FDG PET\/CT bone\/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging","volume":"37","author":"Moulin-Romsee","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"36","key":"10.1093\/annonc\/mdy250_bb0085","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1200\/JCO.2012.42.4036","article-title":"Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography\/computed tomography-staged treatment-naive patients with Hodgkin lymphoma","volume":"30","author":"El-Galaly","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1093\/annonc\/mdy250_bb0090","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00259-014-2706-x","article-title":"Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET\/CT","volume":"41","author":"Weiler-Sagie","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1093\/annonc\/mdy250_bb0095","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ajh.24044","article-title":"The role of bone marrow biopsy and FDG-PET\/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients","volume":"90","author":"Chen-Liang","year":"2015","journal-title":"Am J Hematol"},{"issue":"26","key":"10.1093\/annonc\/mdy250_bb0100","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1200\/JCO.2010.32.4996","article-title":"[18F]fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma","volume":"29","author":"Purz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1093\/annonc\/mdy250_bb0105","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/cncr.10364","article-title":"Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy","volume":"94","author":"Wang","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"10.1093\/annonc\/mdy250_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-82-3-365","article-title":"Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases","volume":"82","author":"Brunning","year":"1975","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1093\/annonc\/mdy250_bb0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2967\/jnumed.116.184218","article-title":"Prognostic value of bone marrow tracer uptake pattern in baseline PET scans in Hodgkin lymphoma: results from an International Collaborative Study","volume":"58","author":"Zwarthoed","year":"2017","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1093\/annonc\/mdy250_bb0120","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00259-009-1183-0","article-title":"Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?","volume":"36","author":"Salaun","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1093\/annonc\/mdy250_bb0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MNM.0000000000000400","article-title":"Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?","volume":"37","author":"Adams","year":"2016","journal-title":"Nucl Med Commun"},{"issue":"8","key":"10.1093\/annonc\/mdy250_bb0130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.rlu.0000079394.76990.08","article-title":"Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging","volume":"28","author":"Chiang","year":"2003","journal-title":"Clin Nucl Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419341717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419341717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/29\/9\/1926\/25845160\/mdy250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T04:52:02Z","timestamp":1624683122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419341717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0923753419341717"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdy250","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}